Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic effects of LCZ696 vs amlodipine in obese hypertensive subjects
2012-002606-40Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sacubitril + valsartan in essential hypertension, obesity, sponsored by Novartis. Started Jul 2012; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
essential hypertensionobesity
Beyond the preview
Go deeper on 2012-002606-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002606-40.